Bradley R. Ringeisen

Innovative Genomics Institute

Papers

2

Total Citations

27

H-Index

2

About

Bradley R. Ringeisen is a researcher whose work has made meaningful contributions to the field of infectious disease surveillance and molecular diagnostics, particularly in the context of large-scale public health challenges. His most recognized research centers on the development and optimization of high-throughput testing methodologies for SARS-CoV-2, with a focus on saliva-based detection systems that improve accessibility and scalability in pandemic settings. Ringeisen's most cited work, "Robotic RNA Extraction for SARS-CoV-2 Surveillance Using Saliva Samples" (2021), demonstrates his commitment to translating laboratory innovation into practical public health tools. By leveraging robotic automation for RNA extraction from saliva specimens, his research addresses a critical bottleneck in COVID-19 surveillance — enabling asymptomatic testing across large populations without the discomfort or logistical burden of traditional nasopharyngeal swabs. The study's direct-to-RT-qPCR approach streamlines the diagnostic pipeline, reducing both time and resource requirements. Garnering 18 citations, this work has resonated within the diagnostics and epidemiology communities. Ringeisen's research exemplifies how engineering-driven solutions can meaningfully strengthen public health infrastructure during times of crisis.

Research Focus

Key Achievements

2
H-Index
2
Papers
27
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples
18 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Innovative Genomics Institute

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 1 days ago